Cognito Therapeutics raised $105 million for its Alzheimer's treatment device, Spectris, awaiting FDA clearance post-clinical trial results; this significant funding underscores growing investor interest in innovative neurodegenerative disease treatments, encouraging content creators to focus on emerging medical technologies and their potential impacts.
Read the full article at STAT News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





